Related Experiment Video
Updated: May 2, 2026

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections
Published on: October 31, 2017
[Prospects of using miramistin for individual prevention of sexual HIV transmission]
Abstract:
For more than 20 years cationic surfactant Miramistin has been used in Russia and Ukraine as an antiseptic mean for individual prophylaxis of venereal diseases and for the treatment of genitourinary tract and other systems infections. Complete inhibition of HIV-1 activity in vitro by Miramistin in concentrations higher than 0.0075%, has been demonstrated, that allows to consider this detergent as a potent first-generation vaginal microbicide for the prevention of HIV transmission. Higher anti-HIV effect of Miramistin than of nonoxynol-9 and low local toxicity show good prospects of using Miramistin for individual prevention of HIV transmission.
Insights
Miramistin, a cationic surfactant, effectively inhibits HIV-1 in vitro. Its potent anti-HIV activity and low toxicity suggest promise as a vaginal microbicide for preventing HIV transmission.
Area of Science:
- Microbiology
- Virology
- Public Health
Background:
- Cationic surfactant Miramistin has been utilized for over two decades in Russia and Ukraine.
- It serves as an antiseptic for preventing venereal diseases and treating infections across various systems.
Purpose of the Study:
- To evaluate Miramistin's potential as a vaginal microbicide for preventing HIV transmission.
- To compare its efficacy and toxicity against established agents like nonoxynol-9.
Main Methods:
- In vitro assessment of Miramistin's activity against Human Immunodeficiency Virus type 1 (HIV-1).
- Determination of the minimum inhibitory concentration (MIC) for complete HIV-1 inhibition.
- Evaluation of local toxicity profiles.
Main Results:
- Miramistin demonstrated complete inhibition of HIV-1 activity in vitro at concentrations exceeding 0.0075%.
- The anti-HIV effect of Miramistin was found to be superior to that of nonoxynol-9.
- Miramistin exhibited low local toxicity.
Conclusions:
- Miramistin shows significant potential as a first-generation vaginal microbicide for HIV prevention.
- Its potent anti-HIV activity and favorable safety profile warrant further investigation for widespread use.
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

